Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado–Joseph disease

Autophagy in Health and Disease: A Double-Edged Sword

Shintani, T., & Klionsky, D. J. (2004) · Science · doi:10.1126/science.1099993 · Cited by 2,531 · see citing works

Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease

Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347 · see citing works

Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene

Qu, X., Yu, J., Bhagat, G., Furuya, N., Hibshoosh, H., Troxel, A., Rosen, J., Eskelinen, E.-L., Mizushima, N., Ohsumi, Y., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20039 · Cited by 2,311 · see citing works

Impairment of the Ubiquitin-Proteasome System by Protein Aggregation

Bence, N., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,192 · see citing works

Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor

Yue, Z., Jin, S., Yang, C., Levine, A. J., & Heintz, N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2436255100 · Cited by 2,116 · see citing works

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1

Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., Nakamura, S., Nishimura, M., Akiguchi, I., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-221 · Cited by 1,753 · see citing works

Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages

Matsunaga, K., Saitoh, T., Tabata, K., Omori, H., Satoh, T., Kurotori, N., Maejima, I., Shirahama-Noda, K., Ichimura, T., Isobe, T., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1846 · Cited by 1,235 · see citing works

The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice.

Pickford, F., Masliah, E., Britschgi, M., Lucin, K. M., Narasimhan, R., Jaeger, P. A., Small, S., Spencer, B., Rockenstein, E., Levine, B., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33585 · Cited by 1,186 · see citing works

Beclin 1 Forms Two Distinct Phosphatidylinositol 3-Kinase Complexes with Mammalian Atg14 and UVRAG

Itakura, E., Kishi, C., Inoue, K., & Mizushima, N. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-01-0080 · Cited by 1,176 · see citing works

Protection against Fatal Sindbis Virus Encephalitis by Beclin, a Novel Bcl-2-Interacting Protein

Liang, X. H., Kleeman, L. K., Jiang, H., Gordon, G. W., Goldman, J. E., Berry, G., Herman, B. A., & Levine, B. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8586-8596.1998 · Cited by 1,128 · see citing works

Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease

Yamamoto, A., Lucas, J. J., & Hen, R. (2000) · Cell · doi:10.1016/s0092-8674(00)80623-6 · Cited by 1,068 · see citing works

Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.

Schöls, L., Bauer, P., Schmidt, T., Schulte, T., & Riess, O. (2004) · Lancet Neurology · doi:10.1016/s1474-4422(04)00737-9 · Cited by 1,007 · see citing works

Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1–phosphatidylinositol-3-kinase complex

Zhong, Y., Wang, Q. J., Li, X., Yan, Y., Backer, J. M., Chait, B. T., Heintz, N., & Yue, Z. (2009) · Nature Cell Biology · doi:10.1038/ncb1854 · Cited by 1,005 · see citing works

Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease Mutation

Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03248.1999 · Cited by 949 · see citing works

Autophagy gone awry in neurodegenerative diseases

Wong, E. S. P., & Cuervo, A. M. (2010) · Nature Neuroscience · doi:10.1038/nn.2575 · Cited by 883 · see citing works

Intranuclear Inclusions of Expanded Polyglutamine Protein in Spinocerebellar Ataxia Type 3

Paulson, H. L., Perez, M. K., Trottier, Y., Trojanowski, J. Q., Subramony, S. H., Das, S. S., Vig, P. J. S., Mandel, J., Fischbeck, K. H., & Pittman, R. N. (1997) · Neuron · doi:10.1016/s0896-6273(00)80943-5 · Cited by 830 · see citing works

Autophagy: in sickness and in health

Cuervo, A. M. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.12.002 · Cited by 816 · see citing works

Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body Diseases

Spencer, B., Potkar, R., Trejo, M., Rockenstein, E., Patrick, C., Gindi, R., Adame, A., Wyss-Coray, T., & Masliah, E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4390-09.2009 · Cited by 595 · see citing works

Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase

Sun, Q., Fan, W., Chen, K., Ding, X., Chen, S., & Zhong, Q. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810452105 · Cited by 504 · see citing works

Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1

Shibata, M., Lu, T., Furuya, T., Degterev, A., Mizushima, N., Yoshimori, T., MacDonald, M., Yankner, B., & Yuan, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600364200 · Cited by 458 · see citing works

Eukaryotic Proteasomes Cannot Digest Polyglutamine Sequences and Release Them during Degradation of Polyglutamine-Containing Proteins

Venkatraman, P., Wetzel, R. B., Tanaka, M., Nukina, N., & Goldberg, A. L. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00151-0 · Cited by 424 · see citing works

Recovery from Polyglutamine-Induced Neurodegeneration in Conditional <i>SCA1</i> Transgenic Mice

Zu, T., Duvick, L. A., Kaytor, M. D., Berlinger, M. S., Zoghbi, H. Y., Clark, H. B., & Orr, H. T. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2978-04.2004 · Cited by 262 · see citing works

Molecular pathogenesis of spinocerebellar ataxias

Matilla‐Dueñas, A. (2006) · Brain · doi:10.1093/brain/awl081 · Cited by 258 · see citing works

Lentiviral-Mediated Delivery of Mutant Huntingtin in the Striatum of Rats Induces a Selective Neuropathology Modulated by Polyglutamine Repeat Size, Huntingtin Expression Levels, and Protein Length

de Almeida, L. P., Ross, C. A., Zala, D., Aebischer, P., & Déglon, N. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03473.2002 · Cited by 226 · see citing works

Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 3

Chen, X., Tang, T.-S., Tu, H., Nelson, O. L., Pook, M. A., Hammer, R. E., Nukina, N., & Борисович, Б. И. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3909-08.2008 · Cited by 216 · see citing works

Regulation of Amyloid Precursor Protein Processing by the Beclin 1 Complex

Jaeger, P. A., Pickford, F., Sun, C.-H. J., Lucin, K. M., Masliah, E., & Wyss‐Coray, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011102 · Cited by 204 · see citing works

Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado–Joseph disease

Nascimento-Ferreira, I., Santos‐Ferreira, T., Sousa-Ferreira, L., Aurégan, G., Onofre, I., Alves, S., Dufour, N., Gould, V. F. C., Koeppen, A. H., Déglon, N., et al. (2011) · Brain · doi:10.1093/brain/awr047 · Cited by 201 · see citing works

A Mutant Ataxin-3 Putative-Cleavage Fragment in Brains of Machado-Joseph Disease Patients and Transgenic Mice Is Cytotoxic above a Critical Concentration

Goti, D., Katzen, S. M., Mez, J. B., Kurtis, N., Kiluk, J., Ben-Haı̈em, L., Jenkins, N. A., Copeland, N. G., Kakizuka, A., Sharp, A. H., et al. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2734-04.2004 · Cited by 191 · see citing works

The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies

Bauer, P. O., & Nukina, N. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06302.x · Cited by 178 · see citing works

Machado‐Joseph disease: An autosomal dominant motor system degeneration

Rosenberg, R. N. (1992) · Movement Disorders · doi:10.1002/mds.870070302 · Cited by 165 · see citing works

Neuroprotective Effect of a CNTF-Expressing Lentiviral Vector in the Quinolinic Acid Rat Model of Huntington's Disease

de Almeida, L. P., Zala, D., Aebischer, P., & Déglon, N. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0388 · Cited by 156 · see citing works

Dose-Dependent Neuroprotective Effect of Ciliary Neurotrophic Factor Delivered via Tetracycline-Regulated Lentiviral Vectors in the Quinolinic Acid Rat Model of Huntington's Disease

Régulier, E., de Almeida, L. P., Sommer, B., Aebischer, P., & Déglon, N. (2002) · Human Gene Therapy · doi:10.1089/10430340260355383 · Cited by 116 · see citing works

Lentivector‐mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia

Torashima, T., Koyama, C., Iizuka, A., Mitsumura, K., Takayama, K., Yanagi, S., Oue, M., Yamaguchi, H., & Hirai, H. (2008) · EMBO Reports · doi:10.1038/embor.2008.31 · Cited by 114 · see citing works

Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3.

Boy, J., Schmidt, T., Wolburg, H., Mack, A., Nuber, S., Böttcher, M., Schmitt, I., Holzmann, C., Zimmermann, F., Servadio, A., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp381 · Cited by 103 · see citing works

Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease

Alves, S., Régulier, E., Nascimento-Ferreira, I., Hässig, R., Dufour, N., Koeppen, A. H., Carvalho, A. L., Simões, S., de Lima, M. C. P., Brouillet, E., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn106 · Cited by 96 · see citing works

Emerging pathogenic pathways in the spinocerebellar ataxias

Carlson, K. M., Andresen, J. M., & Orr, H. T. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.02.009 · Cited by 84 · see citing works

Autophagy plays an important role in Sunitinib-mediated cell death in H9c2 cardiac muscle cells

Zhao, Y., Xue, T., Yang, X., Zhu, H., Ding, X., Lou, L., Lu, W. P., Yang, B., & He, Q. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.07.007 · Cited by 76 · see citing works

Lapatinib Induces Autophagy, Apoptosis and Megakaryocytic Differentiation in Chronic Myelogenous Leukemia K562 Cells

Huang, H.-L., Chen, Y.-C. D., Huang, Y., Yang, K., Pan, H. Y., Shih, S., & Chen, Y.-J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029014 · Cited by 64 · see citing works

Machado-Joseph disease.

Sudarsky, L. R., & Coutinho, P. (1995) · PubMed · Cited by 56 · see citing works

Imatinib induces autophagy throughBECLIN‐1andATG5genes in chronic myeloid leukemia cells

Can, G., Ekiz, H. A., & Baran, Y. (2011) · Hematology · doi:10.1179/102453311x12902908412039 · Cited by 41 · see citing works

Overexpression of Mutant Ataxin-3 in Mouse Cerebellum Induces Ataxia and Cerebellar Neuropathology

Nóbrega, C., Nascimento-Ferreira, I., Onofre, I., Albuquerque, D., Conceição, M., Déglon, N., & de Almeida, L. P. (2012) · The Cerebellum · doi:10.1007/s12311-012-0432-0 · Cited by 36 · see citing works

Joseph disease: an autosomal dominant motor system degeneration.

Rosenberg, R. N. (1984) · PubMed · Cited by 27 · see citing works

Characterization of mutant mice that express polyglutamine in cerebellar Purkinje cells

Oue, M., Mitsumura, K., Torashima, T., Koyama, C., Yamaguchi, H., Furuya, N., & Hirai, H. (2008) · Brain Research · doi:10.1016/j.brainres.2008.12.014 · Cited by 16 · see citing works

Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing

Boland, B., Yu, W. H., Corti, O., Mollereau, B., Henriques, A., Bézard, E., Pastores, G., Rubinsztein, D. C., Nixon, R. A., Duchen, M. R., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.109 · Cited by 552 · see citing works

PINK1 and BECN1 relocalize at mitochondria-associated membranes during mitophagy and promote ER-mitochondria tethering and autophagosome formation

Gelmetti, V., Rosa, P. D., Torosantucci, L., Marini, E. S., Romagnoli, A., Rienzo, M. D., Arena, G., Vignone, D., Fimia, G. M., & Valente, E. M. (2017) · Autophagy · doi:10.1080/15548627.2016.1277309 · Cited by 355 · see citing works

Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation?

Marcelo, A., Koppenol, R., de Almeida, L. P., Matos, C. A., & Nóbrega, C. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03873-8 · Cited by 247 · see citing works

Autophagy Induction as a Therapeutic Strategy for Neurodegenerative Diseases

Djajadikerta, A., Keshri, S., Tanasa, M. P., Prestil, R., Ryan, L., & Rubinsztein, D. C. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.035 · Cited by 238 · see citing works

Mutation in ATG5 reduces autophagy and leads to ataxia with developmental delay

Kim, M., Sandford, E., Gatica, D., Qiu, Y., Liu, X., Zheng, Y., Schulman, B. A., Xu, J., Semple, I., Ro, S.-H., et al. (2016) · eLife · doi:10.7554/elife.12245 · Cited by 225 · see citing works

Beclin 1, an Essential Component and Master Regulator of PI3K-III in Health and Disease

McKnight, N. C., & Yue, Z. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0028-5 · Cited by 187 · see citing works

Autophagic and endo-lysosomal dysfunction in neurodegenerative disease

Malik, B. R., Maddison, D. C., Smith, G. A., & Peters, O. M. (2019) · Molecular Brain · doi:10.1186/s13041-019-0504-x · Cited by 180 · see citing works

Targeting autophagy in neurodegenerative diseases

Vidal, R. L., Matus, S., Bargsted, L., & Hetz, C. A. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.002 · Cited by 145 · see citing works

Machado–Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy

Matos, C. A., de Almeida, L. P., & Nóbrega, C. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14541 · Cited by 145 · see citing works

Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice

McLoughlin, H. S., Moore, L. R., Chopra, R., Komlo, R., McKenzie, M., Blumenstein, K. G., Zhao, H. T., Kordasiewicz, H. B., Shakkottai, V. G., & Paulson, H. L. (2018) · Annals of Neurology · doi:10.1002/ana.25264 · Cited by 140 · see citing works

Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases

Duarte‐Neves, J., de Almeida, L. P., & Cavadas, C. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.022 · Cited by 137 · see citing works

Caloric restriction blocks neuropathology and motor deficits in Machado-Joseph disease mouse models through SIRT1 pathway

Cunha-Santos, J., Duarte-Neves, J., Carmona, V., Guarente, L., Pereira de Almeida, L., & Cavadas, C. (2016) · Nature Communications · doi:10.1038/ncomms11445 · Cited by 109 · see citing works

Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future

Piguet, F., Alves, S., & Cartier, N. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.160 · Cited by 109 · see citing works

Crosstalk Between Macroautophagy and Chaperone-Mediated Autophagy: Implications for the Treatment of Neurological Diseases

Wu, H., Chen, S., Al-Baadani, A., Xu, J., Wu, Q., Pan, K., Zhang, J., & Hong, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8933-0 · Cited by 99 · see citing works

Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease

Teixeira‐Castro, A., Jalles, A., Esteves, S., Kang, S., Santos, L. D. S., Silva‐Fernandes, A., Neto, M. F., Brielmann, R. M., Bessa, C., Duarte‐Silva, S., et al. (2015) · Brain · doi:10.1093/brain/awv262 · Cited by 88 · see citing works

Transplantation of cerebellar neural stem cells improves motor coordination and neuropathology in Machado-Joseph disease mice

Mendonça, L. S., Nóbrega, C., Hirai, H., Kaspar, B. K., & de Almeida, L. P. (2014) · Brain · doi:10.1093/brain/awu352 · Cited by 87 · see citing works

Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia

Nóbrega, C., Mendonça, L. S., Marcelo, A., Lamazière, A., Tomé, S. O., Després, G., Matos, C. A., Mechmet, F., Langui, D., den Dunnen, W. F. A., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02019-7 · Cited by 83 · see citing works

Mitophagy in Parkinson’s Disease: Pathogenic and Therapeutic Implications

Gao, F., Yang, J. Y., Wang, D., Li, C., Fu, Y., Wang, H., He, W., & Zhang, J. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00527 · Cited by 82 · see citing works

Let-7 Coordinately Suppresses Components of the Amino Acid Sensing Pathway to Repress mTORC1 and Induce Autophagy

Dubinsky, A. N., Dastidar, S. G., Hsu, C. L., Zahra, R., Djakovic, S. N., Duarte, S., Esau, C., Spencer, B. J., Ashe, T. D., Fischer, K. M., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.001 · Cited by 81 · see citing works

Primary and secondary ataxias

Teive, H. A. G., & Ashizawa, T. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000227 · Cited by 77 · see citing works

From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation

Silva, J. D. D., Teixeira‐Castro, A., & Maciel, P. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00798-1 · Cited by 73 · see citing works

The autophagy/lysosome pathway is impaired in SCA7 patients and SCA7 knock-in mice

Alves, S., Cormier‐Dequaire, F., Marinello, M., Marais, T., Muriel, M., Beaumatin, F., Charbonnier‐Beaupel, F., Tahiri, K., Seilhean, D., Hachimi, K. H. E., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1289-8 · Cited by 71 · see citing works

From Pathways to Targets: Understanding the Mechanisms behind Polyglutamine Disease

Weber, J. J., Sowa, A. S., Binder, T., & Hübener‐Schmid, J. (2014) · BioMed Research International · doi:10.1155/2014/701758 · Cited by 69 · see citing works

Calpain Inhibition Is Protective in Machado–Joseph Disease Zebrafish Due to Induction of Autophagy

Watchon, M., Yuan, K. C., Mackovski, N., Svahn, A. J., Cole, N. J., Goldsbury, C. S., Rinkwitz, S., Becker, T. S., Nicholson, G. A., & Laird, A. S. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1142-17.2017 · Cited by 68 · see citing works

Treatment of Spinocerebellar Ataxia with Mesenchymal Stem Cells: A Phase I/IIa Clinical Study

Tsai, Y., Liu, R.-S., Lirng, J.-F., Yang, B., Chang, C., Wang, Y.-C., Wu, Y., Ho, J. H., Lee, O. K., & Soong, B. (2017) · Cell Transplantation · doi:10.3727/096368916x694373 · Cited by 66 · see citing works

Beclin 1 Biology and its Role in Heart Disease

Zhu, H., & He, L. (2015) · Current Cardiology Reviews · doi:10.2174/1573403x10666141106104606 · Cited by 59 · see citing works

Autophagy in polyglutamine disease: Imposing order on disorder or contributing to the chaos?

Cortés, C. J., & Spada, A. R. L. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.03.010 · Cited by 58 · see citing works

Deregulation of autophagy in postmortem brains of Machado‐Joseph disease patients

Sittler, A., Muriel, M., Marinello, M., Brice, A., den Dunnen, W. F. A., & Alves, S. (2017) · Neuropathology · doi:10.1111/neup.12433 · Cited by 57 · see citing works

The potential roles of deubiquitinating enzymes in brain diseases

Lim, K., Joo, J., & Baek, K. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101088 · Cited by 56 · see citing works

Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado–Joseph disease

Duarte‐Neves, J., Gonçalves, N., Cunha‐Santos, J., Simões, A. T., den Dunnen, W. F. A., Hirai, H., Kügler, S., Cavadas, C., & de Almeida, L. P. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv271 · Cited by 52 · see citing works

Quercetin exhibits potent antioxidant activity, restores motor and non-motor deficits induced by rotenone toxicity

Madiha, S., Batool, Z., Tabassum, S., Liaquat, L., Sadir, S., Shahzad, S., Naqvi, F. F., Saleem, S., Yousuf, S., Nawaz, A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258928 · Cited by 51 · see citing works

Re-establishing ataxin-2 downregulates translation of mutant ataxin-3 and alleviates Machado–Joseph disease

Nóbrega, C., Carmo‐Silva, S., Albuquerque, D., Vasconcelos‐Ferreira, A., Vijayakumar, U. G., Mendonça, L. S., Hirai, H., & de Almeida, L. P. (2015) · Brain · doi:10.1093/brain/awv298 · Cited by 44 · see citing works

Cordycepin activates autophagy through AMPK phosphorylation to reduce abnormalities in Machado–Joseph disease models

Marcelo, A., Brito, F., Carmo‐Silva, S., Matos, C. A., Alves-Cruzeiro, J., Vasconcelos‐Ferreira, A., Koppenol, R., Mendonça, L. S., de Almeida, L. P., & Nóbrega, C. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy328 · Cited by 44 · see citing works

Antiparkinsonian activity of Cucurbita pepo seeds along with possible underlying mechanism

Saleem, U., Shehzad, A., Shah, S., Raza, Z., Shah, M. A., Bibi, S., Chauhdary, Z., & Ahmad, B. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00707-6 · Cited by 43 · see citing works

Far-infrared radiation protects viability in a cell model of Spinocerebellar Ataxia by preventing polyQ protein accumulation and improving mitochondrial function

Chang, J., Wu, S., Hoel, F., Cheng, Y.-S., Liu, K.-H., Hsieh, M., Hoel, A., Tronstad, K. J., Yan, K.-C., Hsieh, C., et al. (2016) · Scientific Reports · doi:10.1038/srep30436 · Cited by 39 · see citing works

Repeated Mesenchymal Stromal Cell Treatment Sustainably Alleviates Machado-Joseph Disease

Miranda, C. O., Marcelo, A., Silva, T. P., Barata, J., Vasconcelos‐Ferreira, A., Pereira, D., Nóbrega, C., Duarte, S., Barros, I., Alves, J., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.07.007 · Cited by 37 · see citing works

Proteolytic cleavage of Beclin 1 exacerbates neurodegeneration

Bieri, G., Lucin, K. M., O’Brien, C. E., Zhang, H., Villeda, S., & Wyss‐Coray, T. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0302-4 · Cited by 35 · see citing works

Trehalose alleviates the phenotype of Machado–Joseph disease mouse models

Santana, M. M., Paixão, S., Cunha‐Santos, J., Silva, T. P., Trevino-Garcia, A., Gaspar, L. S., Nóbrega, C., Nobre, R. J., Cavadas, C., Greif, H., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02302-2 · Cited by 32 · see citing works

Clec16a is Critical for Autolysosome Function and Purkinje Cell Survival

Redmann, V., Lamb, C. A., Hwang, S., Orchard, R. C., Kim, S., Razi, M., Milam, A., Park, S., Yokoyama, C. C., Kambal, A., et al. (2016) · Scientific Reports · doi:10.1038/srep23326 · Cited by 31 · see citing works

Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3

Rodríguez‐Cueto, C., Hernández, M., Hillard, C. J., Maciel, P., García‐García, L., Valdeolivas, S., Pozo, M. A., Ramos, J. A., Gómez‐Ruíz, M., & Fernández‐Ruíz, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.09.046 · Cited by 30 · see citing works

n-Butylidenephthalide Modulates Autophagy to Ameliorate Neuropathological Progress of Spinocerebellar Ataxia Type 3 through mTOR Pathway

Lee, J.-H., Lin, S.-Y., Liu, J., Lin, S., Harn, H., & Chiou, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126339 · Cited by 29 · see citing works

Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics

Paulino, R., & Nóbrega, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087405 · Cited by 29 · see citing works

The autophagy‐enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado–Joseph disease

Vasconcelos‐Ferreira, A., Carmo‐Silva, S., Codêsso, J. M., Silva, P., Martinez, A. R. M., França, M. C., Nóbrega, C., & de Almeida, L. P. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12763 · Cited by 27 · see citing works

Caffeine alleviates progressive motor deficits in a transgenic mouse model of spinocerebellar ataxia

Gonçalves, N., Simões, A., Prediger, R., Hirai, H., Cunha, R., & de Almeida, L. P. (2017) · Annals of Neurology · doi:10.1002/ana.24867 · Cited by 31 · see citing works

Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease

Ashraf, N. S., Duarte‐Silva, S., Shaw, E. D., Maciel, P., Paulson, H. L., Teixeira‐Castro, A., & Costa, M. D. C. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1331-2 · Cited by 26 · see citing works

Gene Therapies for Polyglutamine Diseases

Matos, C. A., Carmona, V., Vijayakumar, U. G., Lopes, S., Albuquerque, P., Conceição, M., Nobre, R. J., Nóbrega, C., & de Almeida, L. P. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-71779-1_20 · Cited by 25 · see citing works

Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias

Afonso‐Reis, R., Afonso, I. T., & Nóbrega, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084249 · Cited by 25 · see citing works

RNA Interference Therapy for Machado–Joseph Disease: Long-Term Safety Profile of Lentiviral Vectors Encoding Short Hairpin RNAs Targeting Mutant Ataxin-3

Nóbrega, C., Codêsso, J. M., Mendonça, L. S., & de Almeida, L. P. (2019) · Human Gene Therapy · doi:10.1089/hum.2018.157 · Cited by 24 · see citing works

Deubiquitylating enzymes in neuronal health and disease

Amer‐Sarsour, F., Kordonsky, A., Berdichevsky, Y., Prag, G., & Ashkenazi, A. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03361-5 · Cited by 24 · see citing works

Recent Advances in the Treatment of Cerebellar Disorders

Mitoma, H., Manto, M. U., & Gandini, J. (2019) · Brain Sciences · doi:10.3390/brainsci10010011 · Cited by 23 · see citing works

Neuropeptide Y (NPY) intranasal delivery alleviates Machado–Joseph disease

Duarte‐Neves, J., Cavadas, C., & de Almeida, L. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-82339-5 · Cited by 23 · see citing works

Alternative Messenger RNA Splicing of Autophagic Gene Beclin 1 in Human B-cell Acute Lymphoblastic Leukemia Cells

Niu, Y., Liu, Q.-Q., Zhang, S., Yuan, N., Cao, Y., Cai, J., Lin, W., Xu, F., Wang, Z., Chen, B., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.5.2153 · Cited by 23 · see citing works

Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein

Ashraf, N. S., Sutton, J. R., Yang, Y., Ranxhi, B., Libohova, K., Shaw, E. D., Barget, A. J., Todi, S. V., Paulson, H. L., & Costa, M. D. C. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104697 · Cited by 22 · see citing works

Promoter Variant Alters Expression of the Autophagic BECN1 Gene: Implications for Clinical Manifestations of Machado-Joseph Disease

Kazachkova, N., Raposo, M., Ramos, A., Montiel, R., & Lima, M. C. F. (2017) · The Cerebellum · doi:10.1007/s12311-017-0875-4 · Cited by 20 · see citing works

Genetic enhancement of macroautophagy in vertebrate models of neurodegenerative diseases

Ejlerskov, P., Ashkenazi, A., & Rubinsztein, D. C. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.04.001 · Cited by 20 · see citing works

Amelioration of motor and non-motor deficits and increased striatal APoE levels highlight the beneficial role of pistachio supplementation in rotenone-induced rat model of PD

Haider, S., Madiha, S., & Batool, Z. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00584-5 · Cited by 20 · see citing works

Recent therapeutic prospects for Machado–Joseph disease

Costa, M. D. C. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000832 · Cited by 19 · see citing works

Targeting the prodromal stage of spinocerebellar ataxia type 17 mice: G-CSF in the prevention of motor deficits via upregulating chaperone and autophagy levels

Chang, Y., Lin, C.-W., Hsu, C.-M., Lee‐Chen, G., Su, M., Ro, L., Chen, C., Huang, H.-J., & Hsieh‐Li, H. M. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.004 · Cited by 18 · see citing works

Human Olfactory Ensheathing Cell Transplantation Improves Motor Function in a Mouse Model of Type 3 Spinocerebellar Ataxia

Hsieh, J., Liu, J.-W., Harn, H., Hsueh, K.-W., Rajamani, K., Deng, Y.-C., Chia, C.-M., Shyu, W.-C., Lin, S., & Chiou, T. (2017) · Cell Transplantation · doi:10.1177/0963689717732578 · Cited by 17 · see citing works

ULK overexpression mitigates motor deficits and neuropathology in mouse models of Machado-Joseph disease

Vasconcelos‐Ferreira, A., Martins, I. M., Lobo, D. D., Pereira, D., Lopes, M. M., Faro, R., Lopes, S., Verbeek, D. S., Schmidt, T., Nóbrega, C., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.07.012 · Cited by 17 · see citing works

Sodium valproate increases activity of the sirtuin pathway resulting in beneficial effects for spinocerebellar ataxia-3 in vivo

Watchon, M., Luu, L., Robinson, K. J., Yuan, K. C., Luca, A. D., Suddull, H. J., Tym, M. C., Guillemin, G. J., Cole, N. J., Nicholson, G. A., et al. (2021) · Molecular Brain · doi:10.1186/s13041-021-00839-x · Cited by 17 · see citing works

Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets

Gómez‐Ruíz, M., Rodríguez‐Cueto, C., Luna-Piñel, E., Hernández, M., & Fernández‐Ruíz, J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00094 · Cited by 16 · see citing works

The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington’s disease

Nóbrega, C., Conceição, A., da Costa, R. G., Koppenol, R., Sequeira, R. L., Nunes, R., Carmo‐Silva, S., Marcelo, A., Matos, C. A., Bétuing, S., et al. (2020) · BMC Research Notes · doi:10.1186/s13104-020-05053-x · Cited by 16 · see citing works

Treatment with sodium butyrate induces autophagy resulting in therapeutic benefits for spinocerebellar ataxia type 3

Watchon, M., Robinson, K. J., Luu, L., An, Y., Yuan, K. C., Plenderleith, S. K., Cheng, F., Don, E. K., Nicholson, G. A., Lee, A., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202300963rr · Cited by 15 · see citing works

Autophagy Function and Benefits of Autophagy Induction in Models of Spinocerebellar Ataxia Type 3

Watchon, M., Luu, L., Plenderleith, S. K., Yuan, K. C., & Laird, A. S. (2023) · Cells · doi:10.3390/cells12060893 · Cited by 15 · see citing works

Assessment of gait dynamics in rotenone-induced rat model of Parkinson’s disease by footprint method

Madiha, S., Tabassum, S., Batool, Z., Liaquat, L., Sadir, S., Shahzad, S., Perveen, T., & Haider, S. (2017) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps/30/3(suppl)/03.06.2017/670/943-948 · Cited by 14 · see citing works

Machado–Joseph Disease: A Stress Combating Deubiquitylating Enzyme Changing Sides

Dantuma, N. P., & Herzog, L. K. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_10 · Cited by 14 · see citing works

Erinacine A-Enriched Hericium erinaceus Mycelium Ethanol Extract Lessens Cellular Damage in Cell and Drosophila Models of Spinocerebellar Ataxia Type 3 by Improvement of Nrf2 Activation

Wu, Y., Sun, H., Chang, J., Lin, W., Chen, P., Chen, C., Lee, L., Li, C., Hsieh, M., Chen, H., et al. (2024) · Antioxidants · doi:10.3390/antiox13121495 · Cited by 13 · see citing works

Preclinical Assessment of Mesenchymal-Stem-Cell-Based Therapies in Spinocerebellar Ataxia Type 3

Correia, J. S., Neves‐Carvalho, A., Mendes-Pinheiro, B., Pires, J. P., Teixeira, F. G., Lima, R., Monteiro, S., Silva, N. A., Soares‐Cunha, C., Serra, S. C., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9121754 · Cited by 13 · see citing works

The curative and mechanistic acumen of curcuminoids formulations against haloperidol induced Parkinson’s disease animal model

Saleem, U., Khalid, S., Chauhdary, Z., Anwar, F., Shah, M. A., Alsharif, I., Babalghith, A. O., Khayat, R. O. S., Albalawi, A. E., Baokbah, T. A. S., et al. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01122-1 · Cited by 11 · see citing works

Therapeutic Effects of Curcuma longa against Rotenone-Induced Gross Motor Skill Deficits in Rats

Madiha, S., Batool, Z., Tabassum, S., Liaquat, L., Sadir, S., Perveen, T., & Haider, S. (2018) · Pakistan Journal of Zoology · doi:10.17582/journal.pjz/2018.50.4.1245.1256 · Cited by 11 · see citing works

Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects

Bonsor, M., Ammar, O., Schnoegl, S., Wanker, E. E., & Ramos, E. S. (2024) · PROTEOMICS · doi:10.1002/pmic.202300114 · Cited by 10 · see citing works

Transcription factor EB-mediated mesenchymal stem cell therapy induces autophagy and alleviates spinocerebellar ataxia type 3 defects in neuronal cells model

Han, X. B., Habimana, J. D. D., Li, A. L., Huang, R., Mukama, O., Deng, W., Wang, L., Zhang, Y., Wang, W., Deng, S., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05085-0 · Cited by 10 · see citing works

Experimental and Clinical Strategies for Treating Spinocerebellar Ataxia Type 3

Wang, Z. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.11.051 · Cited by 10 · see citing works

Autophagy and Polyglutamine Disease

Ren, H., Hao, Z., & Wang, G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-4272-5_9 · Cited by 10 · see citing works

Regulation of Autophagy in Neurodegenerative Diseases: A Brief Review on Autophagy Therapy for Neurodegenerative Diseases

Kanda, A., Mazumder, A., Das, S., Prabhakar, V., Singh, T., Kumari, S., & Mishra, A. (2023) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.13.1.68 · Cited by 9 · see citing works

Gene Therapy Strategies: Gene Augmentation

Nóbrega, C., Mendonça, L. S., & Matos, C. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-41333-0_6 · Cited by 9 · see citing works

Molecular targets and approaches to restore autophagy and lysosomal capacity in neurodegenerative disorders

Bastien, J., Menon, S., Messa, M., & Nyfeler, B. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101018 · Cited by 9 · see citing works

Mutant Ataxin-2 Expression in Aged Animals Aggravates Neuropathological Features Associated with Spinocerebellar Ataxia Type 2

Afonso, I. T., Lima, P., Conceição, A., Matos, C. A., & Nóbrega, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911896 · Cited by 7 · see citing works

Arginine vasopressin relates with spatial learning and memory in a mouse model of spinocerebellar ataxia type 3

Jiang, H.-B., Du, A., Luo, H., Yang, J., Luo, X.-Q., Ma, R.-Q., Shi, C., & Xu, Y. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.06.001 · Cited by 7 · see citing works

Polymorphisms in DNA methylation–related genes are linked to the phenotype of Machado-Joseph disease

Ding, D., Wang, C., Zhao, C. N., Peng, H., Li, K., Zhou, X., Peng, Y., Wang, P., Hou, X., Li, T., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.11.002 · Cited by 7 · see citing works

Benzoic-D5 acid as D2 receptor agonist in the treatment of rotenone induced Parkinson’s disease in mice

Zaidi, S. A. A., Khan, M. A., Khan, M. R., Ahmed, H., Shaheryar, Z. A., Sahibzada, M. U. K., Alghamdi, S. A., Aljuaid, A., Almehmadi, M. M., & Allahyani, M. A. (2023) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2023.104982 · Cited by 5 · see citing works

Insight into the early pathogenesis and therapeutic strategies of spinocerebellar ataxia type 3/machado–joseph disease from mouse models

Wang, Y., Zhai, Y., & Ju, W. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106991 · Cited by 4 · see citing works

Small Molecules Inducing Autophagic Degradation of Expanded Polyglutamine Protein through Interaction with Both Mutant ATXN3 and LC3

Lin, T., Chen, W.-L., Hsu, S.-F., Chen, I., Lin, C., Chang, K., Wu, Y., Chen, Y., Yao, C., Lin, W., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910707 · Cited by 4 · see citing works

Extracellular vesicles-associated AAVs for the treatment of Machado-Joseph disease

Henriques, C., de Albuquerque, P. R., Rufino‐Ramos, D., Lopes, M. M., Leandro, K., Miranda, C. O., Almeida, R., Lopes-Gabriel, G., de Sousa-Lourenço, J., Lopes, S., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.10.022 · Cited by 3 · see citing works

TCE-mediated neuroprotection against rotenone-induced dopaminergic neuronal death in PD mice: insights into the Nrf-2/PINK1/Parkin-mitophagy pathway

Dilnashin, H., Singh, S. P., Rawat, P., Rathore, A. S., Singh, R., Keshri, P. K., Gupta, N. K., Satyaprakash, S. A., & Singh, S. P. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01595-w · Cited by 3 · see citing works

Mesenchymal stem cells for lysosomal storage and polyglutamine disorders: Possible shared mechanisms

Miranda, C. O. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13707 · Cited by 2 · see citing works

Lurcher Mouse as a Model of Cerebellar Syndromes

Choudhury, N. R., Hilber, P., & Cendelín, J. (2025) · The Cerebellum · doi:10.1007/s12311-025-01810-5 · Cited by 1 · see citing works

Neurodegeneration and the endocannabinoid system: Toward the development of cannabinoid-based therapies for Parkinson's disease, amyotrophic lateral sclerosis and spinocerebellar ataxias

Fernández‐Ruíz, J., Rodríguez-Cueto, C., García, C., Satta, V., Gómez-Cañas, M., Sagredo, O., de Lago, E., & Gómez-Ruiz, M. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00023-2 · Cited by 1 · see citing works

Urolithin A Reverses Intranigral Rotenone-Generated Parkinsonism by Modulating DNA Methyltransferase 1 and α-Synuclein Axis in Rats

Devi, A., Singh, S. B., Srivastava, S., & Dandekar, M. P. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00362 · Cited by 1 · see citing works

AAV-mediated allele-specific silencing alleviates neuropathology in a novel non-human primate model of Spinocerebellar ataxia type 3Preprint

Henriques, C., Lobo, D. D., da Silva, A. C., Fernandes, A. R., Lopes, M. M., Fayard, A., Jan, C., Lecourtois, S., Guillermier, M., Flament, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.02.680027 · Cited by 1 · see citing works

Huntington’s Disease and Other Polyglutamine Repeat Diseases

Dickey, A. S., & Spada, A. R. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00007-9

Gene editing and central nervous system regeneration

Lopes, S. M., & de Almeida, L. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818084-6.00011-8

Faculty Opinions recommendation of Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.

Dürr, A. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733458894.793552253

Development of Mesenchymal Stem Cells Therapy for the Treatment of Polyglutamine SCA: From Bench to Bedside

Ho, C., Lai, H.-Y., Wang, L.-M., & Soong, B. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-24345-5_19

Intermittent Theta-Burst Stimulation (iTBS) Improves Motor Coordination and Modulates Neuroinflammation and Autophagy in SCA3/MJD Mice

Chen, L.-W., Lian, Y.-H., Dong, X.-L., Luo, K.-L., Zhan, L.-Q., Xie, L.-L., Sun, Q.-K., Lin, W. C., Gan, S., Cheng, X.-P., et al. (2026) · The Cerebellum · doi:10.1007/s12311-026-02027-w

Autophagy at the Crossroads of Protein and RNA Toxicity in Repeat Expansion Cerebellar Ataxias

Tortoriello, S., Rossi, S., Valle, I. D., D’Ambrosi, N., & Cozzolino, M. (2026) · Cells · doi:10.3390/cells15151411

Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado–Joseph disease

Nascimento-Ferreira, I., Santos‐Ferreira, T., Sousa-Ferreira, L., Aurégan, G., Onofre, I., Alves, S., Dufour, N., Gould, V. F. C., Koeppen, A. H., Déglon, N., et al. (2011) · Brain · doi:10.1093/brain/awr047 · Cited by 201 · see citing works

Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice. PLoS One 2013

Nascimento-Ferreira, I., Onofre, I., Albuquerque, D., Hirai, H., & de Almeida, L. P. (2016)

Silencing Mutant Ataxin-3 Rescues Motor Deficits and Neuropathology in Machado-Joseph Disease Transgenic Mice

Nóbrega, C., Nascimento-Ferreira, I., Onofre, I., Albuquerque, D., Hirai, H., Déglon, N., & de Almeida, L. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052396 · Cited by 121 · see citing works

Overexpression of Mutant Ataxin-3 in Mouse Cerebellum Induces Ataxia and Cerebellar Neuropathology

Nóbrega, C., Nascimento-Ferreira, I., Onofre, I., Albuquerque, D., Conceição, M., Déglon, N., & de Almeida, L. P. (2012) · The Cerebellum · doi:10.1007/s12311-012-0432-0 · Cited by 36 · see citing works

RNA Interference Mitigates Motor and Neuropathological Deficits in a Cerebellar Mouse Model of Machado-Joseph Disease

Nóbrega, C., Nascimento-Ferreira, I., Onofre, I., Albuquerque, D., Déglon, N., & de Almeida, L. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100086 · Cited by 42 · see citing works